BrainStorm (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinsonâs Disease (PD). Source
No articles found.
Sunesis is a biopharmaceutical company focused on the development and commercializ...
Sunesis is a biopharmaceutical company focused ...
Neurotrope is a clinical-stage biotech company leveraging Bryostatin-1 and its ana...
Neurotrope is a clinical-stage biotech company ...
Allied Healthcare Products, Inc. is a leading manufacturer of medical gas construc...
Allied Healthcare Products, Inc. is a leading m...
ProLung is a medical technology company specializing in innovative predictive anal...
ProLung is a medical technology company special...
Fresenius is a global healthcare group offering high-quality products and services...
Fresenius is a global healthcare group offering...
Histogenics historically focused on the development of restorative cell therapies,...
Histogenics historically focused on the develop...
Fibrocell is a cell and gene therapy company focused on improving the lives of peo...
Fibrocell is a cell and gene therapy company fo...
Histogenics historically focused on the development of restorative cell therapies,...
Histogenics historically focused on the develop...
BioCardia, Inc., headquartered in San Carlos, California, is developing regenerati...
BioCardia, Inc., headquartered in San Carlos, C...
WindowMirror's BUTTERFLY will be a collaborative SaaS (Software as a Service) plat...
WindowMirror's BUTTERFLY will be a collaborativ...
Join the National Investor Network and get the latest information with your interests in mind.